Superhemophobic Surfaces with Improved Hemocompatibility
Available for Licensing
US Utility Patent Pending: US 15/954,943
At A Glance
- Current medical implant surfaces suffer from platelet adhesion / blood clotting
- Researchers at CSU have created novel surfaces to reduce blood clotting
- Market: med devices such as vascular stents, IVC filters, and cardiac occlusion devices
Titanium based implants have created a great deal of attention for their biocompatibility with many different tissues within the human body. However, when these implants come into contact with blood, platelet adhesion and activation occur, which may lead to further thrombosis and sometimes failure of these implants.
Researchers at CSU have created superhemophobic surfaces (surfaces that are extremely repellent to blood). Specifically, a fluorinated titanium surface having a textured morphology of either a nanotube or nanoflower array.
- Significantly reduced platelet adhesion and activation
- Formation of blood clot on superhemophobic surface is negligible
Last updated on October 7, 2019.